Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

South Korea's first HIV-1/2 test to replace imports:

This article was originally published in Clinica

Executive Summary

Korea Green Cross has developed South Korea's first test for HIV-1/2, says Pharma Koreana. Production for the domestic market is due to begin shortly, replacing some Won 2,000 million ($2.6 million) of tests which are imported annually. Jointly developed by teams from Seoul National University's Genetic Engineering Institute and the Korea Institute of Science and Technology, Genedia HIV-1/2 is a third-generation ELISA-based test.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087054

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel